Iovance Biotherapeutics Inc (IOVA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.23 -0.18 (-5.28%) 04/15/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.22 -0.01 (-0.31%) 19:58 ET
for Tue, Apr 15th, 2025
Results
download Want to compare other data? Select Fields| Symbol | IOVA | PCRX | GPCR | ||
| Company | Iovance Biotherapeutics Inc | Pacira Pharm Inc | Structure Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.36 | 24.80 | 18.80 | ||
| High | 3.47 | 25.14 | 19.78 | ||
| Low | 3.18 | 24.30 | 18.52 | ||
| Last | 3.23 | 24.88 | 18.90 | ||
| Change | -0.18 | -0.09 | -0.05 | ||
| % Change | -5.28% | -0.36% | -0.26% | ||
| Volume | 6,708,000 | 503,400 | 884,800 | ||
| 20-Day Average Volume | 9,702,375 | 1,157,470 | 945,740 | ||
| Previous Close | 3.41 | 24.97 | 18.95 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.35 | 24.53 | 18.03 | ||
| 20-Day Raw Stochastic | 52.69% | 52.82% | 55.36% | ||
| 20-Day Relative Strength | 39.64% | 52.45% | 47.27% | ||
| Weighted Alpha | -73.74 | +61.70 | -61.28 | ||
| Today's Opinion | 100% Sell | 80% Buy | 88% Sell | ||
| Previous Opinion | 88% Sell | 80% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 56% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.33% since 04/08/25 | -5.29% since 04/08/25 | +33.57% since 04/08/25 | ||
| Low | 2.73 on 04/09/25 | 22.12 on 04/09/25 | 13.22 on 04/09/25 | ||
| High | 3.47 on 04/15/25 | 26.02 on 04/09/25 | 19.78 on 04/15/25 | ||
| 1-Month | |||||
| %Chg | -10.03% since 03/14/25 | +8.79% since 03/14/25 | -10.21% since 03/14/25 | ||
| Low | 2.70 on 04/07/25 | 21.79 on 04/07/25 | 13.22 on 04/09/25 | ||
| High | 3.84 on 03/17/25 | 27.64 on 04/08/25 | 23.48 on 03/19/25 | ||
| 3-Month | |||||
| %Chg | -45.35% since 01/15/25 | +13.71% since 01/15/25 | -29.71% since 01/15/25 | ||
| Low | 2.70 on 04/07/25 | 21.25 on 01/16/25 | 13.22 on 04/09/25 | ||
| High | 6.50 on 01/27/25 | 27.64 on 04/08/25 | 31.72 on 01/31/25 | ||
| 6-Month | |||||
| %Chg | -66.32% since 10/15/24 | +49.07% since 10/15/24 | -47.93% since 10/15/24 | ||
| Low | 2.70 on 04/07/25 | 16.00 on 11/18/24 | 13.22 on 04/09/25 | ||
| High | 12.51 on 11/07/24 | 27.64 on 04/08/25 | 42.57 on 10/31/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,118,061 | 1,155,512 | 1,086,650 | ||
| Shares Outstanding, K | 327,877 | 46,276 | 57,343 | ||
| Annual Sales | 164,070,000 | 700,970,000 | 0 | ||
| Annual Net Income | -372,180,000 | -99,560,000 | -122,530,000 | ||
| Last Quarter Sales | 73,690,000 | 187,250,000 | 0 | ||
| Last Quarter Net Income | -78,560,000 | 16,040,000 | -36,480,000 | ||
| 60-Month Beta | 1.05 | 0.71 | -1.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 02/27/25 | 0.91 on 02/27/25 | -0.22 on 02/27/25 | ||
| Latest Earnings Date | 05/08/25 | 05/06/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.68 | 0.00 | ||